Solid Biosciences Inc.’s SLDB share price has surged by 5.57%, which has investors questioning if this is right time to sell.

A diagnosis that could shape your future might be resting on outdated rules. For decades, the key number used to flag a ...

Tenaya Therapeutics, Inc.’s TNYA share price has dipped by 6.21%, which has investors questioning if this is right time to ...

BridgeBio's new heart drug — a rival to Pfizer's blockbuster Vyndaqel — smashed sales expectations in its first full quarter ...

Our coverage of ACC 2025 in Chicago dominated our most-read stories, but other news on novel therapies made the list, too.

Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...

Despite formidable competition in the growing transthyretin amyloid cardiomyopathy (ATTR-CM) market, a strong early launch ...

A mom whose daughter died in a crash listened to her heart beat again after it was donated to an eight-year-old girl. Lisa ...

Renowned singer Tank from Taiwan recently underwent a simultaneous heart and liver transplant to treat a serious genetic ...

Maybe you aren't just tired. It could be heart failure. Here are they key symptoms of ATTR-CM to pay attention to.

A new study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine found that heavy ...

A patient died after not receiving test results diagnosing him with cardiomyopathy; when should you settle a medical ...